When was Myriad Genetics founded?

Myriad Genetics was founded in 1991 and raised its 1st funding round 9 years after it was founded.

Where is Myriad Genetics located?

Myriad Genetics is headquartered in United States. It is registered at Salt Lake City, Utah.

How many employees does Myriad Genetics have?

As of Mar 31, 2026, the latest employee count at Myriad Genetics is 2851.

Is Myriad Genetics a funded company?

Myriad Genetics is a funded company, having raised an undisclosed amount across 8 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Jun 29, 2000.

When was the latest funding round of Myriad Genetics?

Myriad Genetics' latest funding was a $***** Post IPO round on Feb 12, 2019, with participation from 0 investor.

What is the annual revenue of Myriad Genetics?

Annual revenue of Myriad Genetics is between $500M and $1B as on Dec 31, 2025

Where does Myriad Genetics rank among its competitors?

Myriad Genetics ranks 7th amongst 519 active competitors, of which 144 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Guardant Health, which secured $350M in Nov, 2025.

Who are the top competitors of Myriad Genetics?

Myriad Genetics' top competitors include Natera, Guardant Health and Fulgent Genetics. Among them, Guardant Health secured the most recent funding round in November, 2025.

Myriad Genetics - 2026 Company Profile, Funding & Competitors

Company Details

Developer of molecular diagnostics and personalized medicine for cancer. The company discovers and commercializes molecular diagnostic tests that determine the risk of developing the disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties. The products include Endopredict for the detection of breast cancer and Prolasis for prostate cancer. It also provides diagnostic tests for hereditary cancers and Rheumatoid arthritis.

Website: myriad.com
Social
Registered Address: Salt Lake City, Utah

Key Metrics

Founded Year

1991

Location

United States

Stage

Public

Latest Funding Round

Post IPO, Feb 12, 2019, $*****

Investors

TriplePoint Capital & 7 more

Ranked

7^th among 519 active competitors

Annual Revenue

$500M - $1B as on Dec 31, 2025

Employee Count

2,851 as on Mar 31, 2026

Investment & Acquisitions

Gateway Genomics & 8 more

Similar Companies

Natera & 661 more

Exit Details

Public

View Myriad Genetics' full profile

Myriad Genetics is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Myriad CIN: 40203134360 , Latvia, Active	Mar 28, 2018	€0 - €1M (As on Dec 31, 2024)	3 (As on Dec 31, 2023)	-
Myriad Genetics Inc CIN: 899923 , United States, Deadpooled	Nov 05, 1992	$500M - $1B (As on Dec 31, 2025)	2700 (As on Dec 31, 2023)	-
Myriad Genetics, Inc. CIN: 870494517 , United States, Active	Dec 26, 999	-	2729 (As on Dec 31, 2024)	-

Myriad Genetics got listed on Oct 05, 1995.

Click here to take a look at Myriad Genetics's IPO in detail

Myriad Genetics has raised funding over 8 rounds. Its first funding round was on Jun 29, 2000. Myriad Genetics has 8 institutional investors.

Here is the list of recent funding rounds of Myriad Genetics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 12, 2019	4101260	Post IPO	9521581	1021782	5117223	5250410
Jan 24, 2011	4782399	Grant (prize money)	4716869	9485429	1277828	HHS
Mar 03, 2010	7551446	Grant (prize money)	7640757	8478170	5449132	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Myriad Genetics's funding rounds and investors

Myriad Genetics' employee count trend

Myriad Genetics has 2,851 employees as of Mar 26. Here is Myriad Genetics's employee count trend over the years:

Employee count trend for Myriad Genetics

Uncover Myriad Genetics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Myriad Genetics include Natera, Guardant Health and Fulgent Genetics. Here is the list of Top 10 competitors of Myriad Genetics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Natera 2004, Redwood City (United States), Public	Developer of cell-free DNA testing for oncology, women’s health, and organ health	$152M	Harmony Partners, Bain Capital Life Sciences ... & 18 others	77/100
2nd	Guardant Health 2012, Redwood City (United States), Public	Developer of digital sequencing technology for cancer detection	$557M	SoftBank Vision Fund, Lightspeed Venture Partners ... & 25 others	75/100
3rd	Fulgent Genetics 2011, Temple City (United States), Acquired	Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer	$34.8M	-	71/100
4th	Foundation Medicine 2010, Cambridge (United States), Acquired	Provider of genomics-based diagnostics test for cancer	$96.5M	Redmile Group, Deerfield & 11 others	70/100
5th	Prenetics 2009, Hong Kong (China), Public	Online platform for genetic and diagnostic health testing that helps identify health risks	$67.6M	Apis Partners, Beyond Ventures & 22 others	69/100
6th	BillionToOne 2015, San Francisco (United States), Public	Provider of cell-free cancer liquid biopsy test	$389M	Hummingbird Ventures, Adams Street Partners ... & 31 others	69/100
7th	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	TriplePoint Capital, New Venturetec & 6 others	64/100
8th	Invitae 2010, San Francisco (United States), Public	Provider of home-based genetic test for individuals	$190M	Perceptive Advisors, Rock Springs Capital ... & 22 others	68/100
9th	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	66/100
10th	Foresight Diagnostics 2020, Aurora (United States), Acquired	Developer of minimally-invasive liquid biopsy test for the detection of cancer	$104M	Foresite Capital, Bluebird Ventures & 6 others	66/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Myriad Genetics's competitors? Click here to see the top ones

Myriad Genetics has made 2 investments in companies including DLF India and RainDance. Myriad Genetics has also acquired 7 companies including Gateway Genomics and Counsyl.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Nov 03, 2022	Acquisition	Gateway Genomics	2015	San Diego (United States)
Mar 29, 2019	Investments	DLF India	1946	Gurugram (India)
May 28, 2018	Acquisition	Counsyl	2007	San Francisco (United States)